Catecholamines inhibit lipid peroxidation in young, aged, and Alzheimer's disease brain

Anne C. Andorn, Miguel Pappolla

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Some catecholamines and indolamines inhibit lipid peroxidation. Recent studies indicate that catecholaminergic inhibition of lipid peroxidation may be receptor mediated in vivo and in cell cultures. Because oxidative stress is one of the hypothesized pathogenic mechanisms for neurodegenerative diseases, including Alzheimer's disease (AD), we hypothesized that catecholaminergic and indolaminergic inhibition of lipid peroxidation would be altered in AD as compared to age-matched non-AD. To test this hypothesis we studied the effect of a variety of neurotransmitters and their antagonists on ascorbate-stimulated lipid peroxidation in membrane fragment preparations derived from postmortem human brain. In this in vitro system, the inhibition of lipid peroxidation by dopamine and serotonin did not appear to be receptor mediated. Further, our findings indicate that there is no apparent effect of age or AD on the inhibition of lipid peroxidation by catecholaminergic and indolaminergic agents.

Original languageEnglish (US)
Pages (from-to)315-320
Number of pages6
JournalFree Radical Biology and Medicine
Volume31
Issue number3
DOIs
StatePublished - Aug 1 2001
Externally publishedYes

Fingerprint

Lipid Peroxidation
Catecholamines
Brain
Alzheimer Disease
Lipids
Neurodegenerative diseases
Oxidative stress
Cell culture
Neurodegenerative Diseases
Neurotransmitter Agents
Dopamine
Serotonin
Oxidative Stress
Cell Culture Techniques
Membranes
Inhibition (Psychology)

Keywords

  • Aging
  • Alzheimer's disease
  • Ascorbate
  • Catecholamines
  • Free radicals
  • Human brain
  • Lipid peroxidation
  • Serotonin

ASJC Scopus subject areas

  • Medicine(all)
  • Toxicology
  • Clinical Biochemistry

Cite this

Catecholamines inhibit lipid peroxidation in young, aged, and Alzheimer's disease brain. / Andorn, Anne C.; Pappolla, Miguel.

In: Free Radical Biology and Medicine, Vol. 31, No. 3, 01.08.2001, p. 315-320.

Research output: Contribution to journalArticle

@article{44a54649dff94595b9ec7483b660e1f4,
title = "Catecholamines inhibit lipid peroxidation in young, aged, and Alzheimer's disease brain",
abstract = "Some catecholamines and indolamines inhibit lipid peroxidation. Recent studies indicate that catecholaminergic inhibition of lipid peroxidation may be receptor mediated in vivo and in cell cultures. Because oxidative stress is one of the hypothesized pathogenic mechanisms for neurodegenerative diseases, including Alzheimer's disease (AD), we hypothesized that catecholaminergic and indolaminergic inhibition of lipid peroxidation would be altered in AD as compared to age-matched non-AD. To test this hypothesis we studied the effect of a variety of neurotransmitters and their antagonists on ascorbate-stimulated lipid peroxidation in membrane fragment preparations derived from postmortem human brain. In this in vitro system, the inhibition of lipid peroxidation by dopamine and serotonin did not appear to be receptor mediated. Further, our findings indicate that there is no apparent effect of age or AD on the inhibition of lipid peroxidation by catecholaminergic and indolaminergic agents.",
keywords = "Aging, Alzheimer's disease, Ascorbate, Catecholamines, Free radicals, Human brain, Lipid peroxidation, Serotonin",
author = "Andorn, {Anne C.} and Miguel Pappolla",
year = "2001",
month = "8",
day = "1",
doi = "10.1016/S0891-5849(01)00580-9",
language = "English (US)",
volume = "31",
pages = "315--320",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Catecholamines inhibit lipid peroxidation in young, aged, and Alzheimer's disease brain

AU - Andorn, Anne C.

AU - Pappolla, Miguel

PY - 2001/8/1

Y1 - 2001/8/1

N2 - Some catecholamines and indolamines inhibit lipid peroxidation. Recent studies indicate that catecholaminergic inhibition of lipid peroxidation may be receptor mediated in vivo and in cell cultures. Because oxidative stress is one of the hypothesized pathogenic mechanisms for neurodegenerative diseases, including Alzheimer's disease (AD), we hypothesized that catecholaminergic and indolaminergic inhibition of lipid peroxidation would be altered in AD as compared to age-matched non-AD. To test this hypothesis we studied the effect of a variety of neurotransmitters and their antagonists on ascorbate-stimulated lipid peroxidation in membrane fragment preparations derived from postmortem human brain. In this in vitro system, the inhibition of lipid peroxidation by dopamine and serotonin did not appear to be receptor mediated. Further, our findings indicate that there is no apparent effect of age or AD on the inhibition of lipid peroxidation by catecholaminergic and indolaminergic agents.

AB - Some catecholamines and indolamines inhibit lipid peroxidation. Recent studies indicate that catecholaminergic inhibition of lipid peroxidation may be receptor mediated in vivo and in cell cultures. Because oxidative stress is one of the hypothesized pathogenic mechanisms for neurodegenerative diseases, including Alzheimer's disease (AD), we hypothesized that catecholaminergic and indolaminergic inhibition of lipid peroxidation would be altered in AD as compared to age-matched non-AD. To test this hypothesis we studied the effect of a variety of neurotransmitters and their antagonists on ascorbate-stimulated lipid peroxidation in membrane fragment preparations derived from postmortem human brain. In this in vitro system, the inhibition of lipid peroxidation by dopamine and serotonin did not appear to be receptor mediated. Further, our findings indicate that there is no apparent effect of age or AD on the inhibition of lipid peroxidation by catecholaminergic and indolaminergic agents.

KW - Aging

KW - Alzheimer's disease

KW - Ascorbate

KW - Catecholamines

KW - Free radicals

KW - Human brain

KW - Lipid peroxidation

KW - Serotonin

UR - http://www.scopus.com/inward/record.url?scp=0035425999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035425999&partnerID=8YFLogxK

U2 - 10.1016/S0891-5849(01)00580-9

DO - 10.1016/S0891-5849(01)00580-9

M3 - Article

C2 - 11461768

AN - SCOPUS:0035425999

VL - 31

SP - 315

EP - 320

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

IS - 3

ER -